BFRI Earnings — Biofrontera Inc. Common Stock Post-ER Performance | BigEarnings
BFRI — Biofrontera Inc. Common Stock
XNAS · Healthcare · Drug Manufacturers - Specialty & Generic
Price$1.59
Market Cap$23.6M
P/E—
52W Range$0.55 – $1.61
Next Earnings2026-11-11
About Biofrontera Inc. Common Stock
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
